ml 9 has been researched along with Metastase in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jiraviriyakul, A; Phattarasakul, K; Sutthiphongchai, T; Tohtong, R | 1 |
| Bradshaw, D; Murphy, C; Myers, CE; Ramos, S; Somlyo, AP; Somlyo, AV | 1 |
| Kaneko, K; Masamune, A; Satoh, A; Satoh, K; Shimosegawa, T | 1 |
3 other study(ies) available for ml 9 and Metastase
| Article | Year |
|---|---|
Dependence of metastatic cancer cell invasion on MLCK-catalyzed phosphorylation of myosin regulatory light chain.
Topics: Adenocarcinoma; Animals; Azepines; Cell Division; Cell Line, Tumor; Cell Movement; Dose-Response Relationship, Drug; Male; Methotrexate; Myosin Light Chains; Myosin-Light-Chain Kinase; Naphthalenes; Neoplasm Invasiveness; Neoplasm Metastasis; Phosphorylation; Prostatic Neoplasms; Rats | 2003 |
Rho-kinase inhibitor retards migration and in vivo dissemination of human prostate cancer cells.
Topics: Amides; Animals; Azepines; Cattle; Cell Division; Cells, Cultured; Chemotaxis; Endothelium, Vascular; Enzyme Inhibitors; Humans; Intracellular Signaling Peptides and Proteins; Male; Mice; Mice, Transgenic; Myosin-Light-Chain Kinase; Myosin-Light-Chain Phosphatase; Neoplasm Invasiveness; Neoplasm Metastasis; Neovascularization, Physiologic; Phosphoprotein Phosphatases; Prostatic Neoplasms; Protein Serine-Threonine Kinases; Pyridines; rho-Associated Kinases; Transplantation, Heterologous; Tumor Cells, Cultured | 2000 |
Myosin light chain kinase inhibitors can block invasion and adhesion of human pancreatic cancer cell lines.
Topics: Azepines; Cell Adhesion; Cell Movement; Cell Survival; Enzyme Inhibitors; Humans; Integrin beta1; Myosin-Light-Chain Kinase; Naphthalenes; Neoplasm Invasiveness; Neoplasm Metastasis; Pancreatic Neoplasms; Tumor Cells, Cultured | 2002 |